Researchers develop 4e, a psilocin derivative that provides sustained serotonin activity without the hallucinogenic effects of magic mushrooms.

Psilocybin—the psychoactive compound in "magic mushrooms"—is gaining scientific attention for its potential in treating ...

Researchers synthesized modified versions of psilocin that retained their activity while producing fewer hallucinogenic-like ...

I found a way to look into the universe,” says non-fiction Australian filmmaker Josef Gatti in his feature debut Phenomena. Paradoxically, it turns out that the wonders of the universe ...

The researchers detected a specific delay of about 18 milliseconds between the waves in the visual cortex and the ...

Taking psilocybin – the psychedelic component of magic mushrooms – eased symptoms of obsessive compulsive disorder among ...

New experiments suggest a biological missing link that helps lock in the long-term benefits of psychedelic-assisted PTSD treatment ...

A psychoactive ingredient found in ayahuasca, a brew used in shamanistic rituals in South America, has shown promise as a treatment for depression in a phase 2a trial. In the study, 34 people living ...

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...

Ancient Greek priestesses may have used hallucinogenic ergot during the Eleusinian Mysteries, rituals carried out by the cult ...

Many researchers have assumed ketamine’s psychedelic effects are central to its therapeutic value. However, a new analysis from King’s College London and the University of Exeter found no link between ...

A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive symptoms in 34 adults with major depressive disorder, according to a ...